Advanced Research and Development and Delivery of Adult and Pediatric Midazolam Autoinjectors That Have…
FY2022 · complete year · data as of 2026-07-11
A single federal award, with both ends of the trail linked.
Award 75A50122C00031 is a contract from the Department of Health and Human Services, $108.8M obligated, FY2022 to FY2030, for Advanced Research and Development and Delivery of Adult and Pediatric Midazolam Autoinjectors That…. It is classified as NAICS 541714 (Research and Development in Biotechnology (except Nanobiotechnology)) and PSC AN13 (Health R&D Services; Health Care Services; Experimental Development). Source
Description
Advanced Research and Development and Delivery of Adult and Pediatric Midazolam Autoinjectors That Have Received Emergency Use Authorization (EUA) or FDA Approval for the Treatment of Status Epilepticus Seizures in Adult and Pediatric Populations (2+